PRTC
Puretech Health
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 2
Sell signal 1
Stock Price Surged Significantly
Gap Up
RSI Overbought
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About PRTC
Puretech Health Plc
A clinical-stage biotherapeutics company that develops products based on insights into the biology of the brain, immune, and gut systems
Pharmaceutical
Invalid Date
11/16/2020
NASDAQ Stock Exchange
56
12-31
Depository Receipts (Ordinary Shares)
6 Tide Street , Suite 400 , Boston , Massachusetts , 02210 United States
--
Puretech Health Plc is a clinical-stage biotherapeutic company dedicated to discovering, developing and commercializing highly differentiated medicines for destructive diseases, including inflammatory and immune diseases, refractory cancers, lymphatic and gastrointestinal diseases, and neurological and neuropsychological diseases, among others.
Company Financials
EPS
PRTC has released its 2022 Q2 earnings. EPS was reported at -0.1, versus the expected 0, missing expectations. The chart below visualizes how PRTC has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
